Literature DB >> 22397658

Tumor heterogeneity and personalized medicine.

Dan L Longo.   

Abstract

Mesh：

Year:  2012        PMID： 22397658     DOI： 10.1056/NEJMe1200656

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  100 in total

Review 1.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

2.  Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.

Authors:  Yang Ni; Francesco C Stingo; Min Jin Ha; Rehan Akbani; Veerabhadran Baladandayuthapani
Journal:  J Am Stat Assoc       Date:  2018-08-15       Impact factor: 5.033

3.  TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.

Authors:  Jiao Wu; Yunpeng Wang; Zheng Jiang
Journal:  J Gastrointest Cancer       Date:  2021-03

4.  Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.

Authors:  Meriam Ayadi; Anaïs Bouygues; Djamila Ouaret; Nathalie Ferrand; Salem Chouaib; Jean-Paul Thiery; Christian Muchardt; Michèle Sabbah; Annette K Larsen
Journal:  Oncotarget       Date:  2015-07-30

5.  Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.

Authors:  Maria Shoaib; Mansoor Ali Merchant Rameez; Syed Ather Hussain; Mohammed Madadin; Ritesh G Menezes
Journal:  Sci Eng Ethics       Date:  2016-11-28       Impact factor: 3.525

6.  From personalized to patient-specific treatment of metastatic melanoma.

Authors:  Robert O Dillman
Journal:  Melanoma Manag       Date:  2015-08-10

7.  Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.

Authors:  Mariella Dono; Carlotta Massucco; Silvana Chiara; Claudia Sonaglio; Marco Mora; Anna Truini; Giannamaria Cerruti; Gabriele Zoppoli; Alberto Ballestrero; Mauro Truini; Manlio Ferrarini; Simona Zupo
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

8.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

Review 9.  Building a personalized medicine infrastructure at a major cancer center.

Authors:  Funda Meric-Bernstam; Carol Farhangfar; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

10.  Introduction: Cancer chemoprevention and its context.

Authors:  Barbara K Dunn; Asad Umar; Ellen Richmond
Journal:  Semin Oncol       Date:  2015-11-10       Impact factor: 4.929
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.